 Blood Glucose
"Blood Glucose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glucose in blood.
| Descriptor ID |
D001786
|
| MeSH Number(s) |
D09.546.359.448.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Blood Glucose".
Below are MeSH descriptors whose meaning is more specific than "Blood Glucose".
This graph shows the total number of publications written about "Blood Glucose" by people in this website by year, and whether "Blood Glucose" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 1 | 2 | 3 | | 1982 | 0 | 7 | 7 | | 1983 | 0 | 5 | 5 | | 1984 | 3 | 7 | 10 | | 1985 | 2 | 2 | 4 | | 1986 | 0 | 5 | 5 | | 1987 | 0 | 4 | 4 | | 1988 | 2 | 7 | 9 | | 1989 | 4 | 2 | 6 | | 1990 | 2 | 8 | 10 | | 1991 | 7 | 11 | 18 | | 1992 | 2 | 10 | 12 | | 1993 | 2 | 13 | 15 | | 1994 | 3 | 9 | 12 | | 1995 | 5 | 11 | 16 | | 1996 | 5 | 16 | 21 | | 1997 | 4 | 11 | 15 | | 1998 | 0 | 7 | 7 | | 1999 | 3 | 7 | 10 | | 2000 | 4 | 10 | 14 | | 2001 | 2 | 11 | 13 | | 2002 | 9 | 7 | 16 | | 2003 | 2 | 6 | 8 | | 2004 | 3 | 16 | 19 | | 2005 | 4 | 12 | 16 | | 2006 | 7 | 17 | 24 | | 2007 | 3 | 7 | 10 | | 2008 | 4 | 10 | 14 | | 2009 | 12 | 19 | 31 | | 2010 | 10 | 10 | 20 | | 2011 | 12 | 14 | 26 | | 2012 | 6 | 13 | 19 | | 2013 | 11 | 14 | 25 | | 2014 | 12 | 20 | 32 | | 2015 | 13 | 19 | 32 | | 2016 | 6 | 15 | 21 | | 2017 | 9 | 19 | 28 | | 2018 | 12 | 19 | 31 | | 2019 | 10 | 14 | 24 | | 2020 | 6 | 8 | 14 | | 2021 | 6 | 14 | 20 | | 2022 | 0 | 6 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Blood Glucose" by people in Profiles.
-
Smith K, Taylor GS, Brunsgaard LH, Walker M, Bowden Davies KA, Stevenson EJ, West DJ. Thrice daily consumption of a novel, premeal shot containing a low dose of whey protein increases time in euglycemia during 7 days of free-living in individuals with type 2 diabetes. BMJ Open Diabetes Res Care. 2022 05; 10(3).
-
Kietsiriroje N, Pearson SM, O'Mahoney LL, West DJ, Ariëns RA, Ajjan RA, Campbell MD. Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study. Diab Vasc Dis Res. 2022 May-Jun; 19(3):14791641221103217.
-
Miller KM, Kanapka LG, Rickels MR, Ahmann AJ, Aleppo G, Ang L, Bhargava A, Bode BW, Carlson A, Chaytor NS, Gannon G, Goland R, Hirsch IB, Kiblinger L, Kruger D, Kudva YC, Levy CJ, McGill JB, O'Malley G, Peters AL, Philipson LH, Philis-Tsimikas A, Pop-Busui R, Salam M, Shah VN, Thompson MJ, Vendrame F, Verdejo A, Weinstock RS, Young L, Pratley R. Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes. Diabetes Technol Ther. 2022 06; 24(6):424-434.
-
Taylor GS, Shaw AC, Smith K, Wason J, McDonald TJ, Oram RA, Stevenson E, Shaw JAM, West DJ. Capturing the real-world benefit of residual ß-cell function during clinically important time-periods in established Type 1 diabetes. Diabet Med. 2022 05; 39(5):e14814.
-
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S125-S143.
-
6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 01 01; 45(Suppl 1):S83-S96.
-
Sun X, Rashid M, Hobbs N, Brandt R, Askari MR, Cinar A. Incorporating Prior Information in Adaptive Model Predictive Control for Multivariable Artificial Pancreas Systems. J Diabetes Sci Technol. 2022 Jan; 16(1):19-28.
-
Bachul P, Borek P, Anteby R, Generette GS, Basto L, Perea L, Wang LJ, Golab K, Tibudan M, Perez-Gutierrez A, Barth R, Fung J, Witkowski P. 207.2: Favorable 5-year Follow Up Outcomes After Islet Transplantation in Patients With Type 1 Diabetes Mellitus at University of Chicago. Transplantation. 2021 12 01; 105(12 Suppl 1):S3.
-
Boland BB, Laker RC, O'Brien S, Sitaula S, Sermadiras I, Nielsen JC, Barkholt P, Roostalu U, Hecksher-Sørensen J, Sejthen SR, Thorbek DD, Suckow A, Burmeister N, Oldham S, Will S, Howard VG, Gill BM, Newton P, Naylor J, Hornigold DC, Austin J, Lantier L, McGuinness OP, Trevaskis JL, Grimsby JS, Rhodes CJ. Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic ß-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries. Mol Metab. 2022 01; 55:101392.
-
Eastman LM, de Los Reyes S, Dude A. The association of immediate postpartum glucose values with persistent insulin resistance in patients with gestational diabetes. Am J Obstet Gynecol MFM. 2022 03; 4(2):100526.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|